跳转至内容
Merck
CN
所有图片(1)

文件

安全信息

MAB9013

Sigma-Aldrich

抗-冠状病毒组抗原抗体，OC-43核蛋白，克隆542-7D

clone 542-7D, Chemicon®, from mouse

登录查看公司和协议定价
所有图片(1)
UNSPSC代码:
12352203
eCl@ss:
32160702
NACRES:
NA.41

生物来源

mouse

质量水平

300

抗体形式

purified immunoglobulin

抗体产品类型

primary antibodies

克隆

542-7D, monoclonal

种属反应性

human

制造商/商品名称

Chemicon®

技术

immunofluorescence: suitable

同位素/亚型

IgG

运输

wet ice

特异性

冠状病毒核蛋白；OC-43株

免疫原

表位：OC-43的核蛋白。

应用

IFA。 最终工作稀释度必须由最终用户确定。
抗冠状病毒组抗原抗体，OC-43核蛋白，克隆542-7D检测冠状病毒组抗原的水平，&已发布&验证可用于IF。
研究子类别
传染病 - 病毒
研究类别
传染病

外形

形式：纯化
纯化免疫球蛋白。提供在pH 7.4的PBS缓冲液中。含0.1%叠氮化钠和载体蛋白。

储存及稳定性

在+4°C下保存长达12个月。 应避免反复冻/融循环。

法律信息

CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany

免责声明

除非我们的目录或产品随附的其他公司文件中另有说明，否则我们的产品预期仅用于研究用途，不得用于任何其他目的，包括但不限于未经授权的商业用途、体外诊断用途、离体或体内治疗用途或对人类或动物的任何类型的消费或应用。

WGK

WGK 2

闪点(°F)

Not applicable

闪点(°C)

Not applicable

法规信息

常规特殊物品

分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ （Lot或Batch）字后找到。

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Ryohei Hirose et al.
mSphere, 6(3) (2021-05-14)
Human coronavirus (HCoV)-OC43 rarely shows a cytopathic effect (CPE) after infection of various cell lines, and the indirect immunoperoxidase assay (IPA), a relatively complex procedure, has long been used as an alternative assay. Because HCoV-OC43 uses cell-surface transmembrane protease serine
Angelo Robotto et al.
Environmental research, 200, 111783-111783 (2021-07-30)
The airborne transmission path for SARS-CoV-2 is of primary scientific and health-related interest as it could actually involve management, accessibility, use and functionality of many activities, including hospitals), schools, workplaces, factories, transport, sport venues and outdoor environment. It is necessary
Sarah E Philo et al.
The Science of the total environment, 760, 144215-144215 (2020-12-20)
Wastewater1 surveillance of SARS-CoV-2 may be a useful supplement to clinical surveillance as it is shed in feces, there are many asymptomatic cases, and diagnostic testing can have capacity limitations and extended time to results. Although numerous studies have utilized
Daniel Poston et al.
medRxiv : the preprint server for health sciences (2020-10-15)
Cross-reactive immune responses elicited by seasonal coronaviruses might impact SARS-CoV-2 susceptibility and disease outcomes. We measured neutralizing activity against SARS-CoV-2 in pre-pandemic sera from patients with prior PCR-confirmed seasonal coronavirus infection. While neutralizing activity against seasonal coronaviruses was detected in
Martina Morokutti-Kurz et al.
PloS one, 16(2), e0237480-e0237480 (2021-02-18)
In the absence of a vaccine and other effective prophylactic or therapeutic countermeasures the severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) remains a significant public health threat. Attachment and entry of coronaviruses including SARS-CoV-2 is mainly mediated by the spike
查看所有相关文献

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门